EAN德尔菲共识:卒中、帕金森病与胶质瘤连接组MRI采集方案
欧洲神经病学学会通过两轮德尔菲调查,就卒中、帕金森病和胶质瘤的连接组分析所需的临床与MRI数据采集方案达成专家共识。共纳入28条声明,涵盖脑MRI、临床结局、认知评估和病例报告表。所有条目最终一致率均达到80%以上,为多中心数据整合提供统一框架。
要点
- 共识方案覆盖临床核心与研究MRI、结局量表、认知评估和CRF四类条目。
- 所有推荐条目经两轮德尔菲投票,一致率均≥80%(范围80.49%–100%)。
- 方案可作为连接组数据采集的模块化基础,未来可扩展神经生理等数据集。
核心结论
- 经两轮德尔菲共识形成的方案可为卒中、帕金森病和胶质瘤的连接组分析提供统一的多尺度数据采集框架。
- 该方案支持未来模块化扩展其他数据集,并可作为其他神经系统疾病脑网络分析的参考模板。
研究设计与样本
- 由欧洲神经病学学会联合Horizon Europe EBRAINS 2.0研究联盟开展,采用在线德尔菲调查方法。
- 邀请536名专家,来自神经肿瘤、运动障碍、神经影像、卒中共4个科学专家组,覆盖30–35个欧洲国家。
- 两轮德尔菲投票中,第一轮135名专家参与,第二轮173名专家参与,每轮均为28条声明。
- 每个条目预设一致率标准为≥80%,涉及临床核心/研究MRI、临床结局、认知评估和病例报告表。
诊断标准与关键数值
- 所有卒中、帕金森病和胶质瘤相关协议条目在第二轮德尔菲后一致率范围为80.49%至100%。
- 协议条目覆盖脑MRI(临床核心/研究)、最低/扩展临床结局、最低/扩展认知评估、病例报告表四类内容。
临床应用与阅片要点
- 实际采集连接组研究数据时,可参照本共识对卒中、帕金森病和胶质瘤分别采用对应条目。
- 临床报告与研究设计中应按协议区分最低评估与扩展评估,保持认知和结局数据采集同质化。
- 病例报告表设计应遵循共识推荐的字段,便于多中心数据合并与连接组分析。
局限性
- 两轮德尔菲调查的专家参与率仅为25%和32%,可能影响共识的代表性。
- 原文未报告各具体条目的详细采集参数,仅提供一致率范围,无法评估影像技术操作细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
INTRODUCTION AND AIMS: The European Academy of Neurology (EAN) joined the Horizon Europe EBRAINS 2.0 research consortium to co-develop recommendations for prospective acquisition and integration of clinical and research core multi-scale human datasets for connectome analysis in stroke, Parkinson's disease (PD), and glioma (GBM).
METHODS: Using an online Delphi survey method, expert consensus was sought on 28 statements for each of the following protocols in stroke, PD and GBM: clinical core/research brain MRI, minimum/extended clinical outcomes, minimum/extended cognition assessments, case report forms (CRF). The level of agreement for each statement was predefined as ≥ 80%. 536 experts from four EAN Scientific Panels (SP) (SP Neuro-oncology [n = 70], SP Movement Disorders [n = 206], SP Neuroimaging [n = 112], SP Stroke [n = 148]) were invited to participate in this Delphi process.
RESULTS: Two Delphi voting rounds were conducted to reach the predefined level of agreement (≥ 80%; range: 80.49%-100%) for all items to establish consensus on protocol recommendations for stroke, PD and GBM. Cumulative response rate from SP experts was 25% (n = 135 from 30 European countries) for the first, and 32% (n = 173 from 35 European countries) for the second Delphi voting round.
DISCUSSION: These consented protocols provide a pragmatic framework for harmonizing multi-scale data acquisition for connectome analyses in stroke, PD, and GBM. Further, these protocols allow future modular extensions for other datasets, e.g., neurophysiological data or non-imaging biomarkers, and serve as a role model for brain network analyses in other neurological disorders.
引用
- Berger, Pini, Salvalaggio, et al. Harmonized Acquisition of Connectome MRI and Clinical Data for Stroke, Parkinson's Disease and Glioma: Delphi-Derived Protocol Recommendations by the European Academy of Neurology. Eur J Neurol. 2026. PMID: 42712147. doi:10.1111/ene.70708
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。